MedTrace Logo

The Role of Melatonin in the Regulation of Blood Coagulation

NCT01741389 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2017-10-16

No results posted yet for this study

Summary

The main aim is to examine the influence of daylight and melatonin on the temporal variations of hemostatic factors with key roles in the hemostatic process and its regulation. Particular emphasis will be on exploring the role of melatonin in hemostasis by comparing subjects with tetraplegia with able-bodied control subjects.

Conditions

  • Spinal Cord Injured, Tetraplegia

Interventions

DRUG

Melatonin ("Circadin")

Sponsors & Collaborators

  • Sunnaas Hospital

    collaborator UNKNOWN

  • Oslo University Hospital

    collaborator OTHER

  • University of Oslo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Norway

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01741389 on ClinicalTrials.gov